Biologicals

Thiomersal

Thiomersal WHO Consultation on the impact of thiomersal on quality, safety & efficacy of vaccines: regulatory perspectives

Geneva, 15-16 April 2002

New Publications

Contacts

Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971